Somatostatin-induced modulation of microglial activity contributes to mitigating Alzheimer’s disease pathology
Brain, Behavior, and Immunity · 2026-08 · 136 · 106563
DOI: 10.1016/j.bbi.2026.106563 ↗Kurz gefasst
Fachartikel in der Zeitschrift Brain, Behavior, and Immunity, 2026-08. Verfasst von Hyeji Jung und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Brain Sciences, Daegu Gyeongbuk Institute of Science and Technology (DGIST), 333 Techno Jungangdae-Ro, Hyeonpoong-Eup, Dalseong-Gun, Da…. Hauptthemen laut MEDLINE: Microglia, Alzheimer Disease, Somatostatin. Die Arbeit nennt 44 Literaturangaben. Gefördert von: Ministry of Science and ICT, South Korea, Daegu Gyeongbuk Institute of Science and Technology, National Research Foundation of Korea.
Themen: Demenz
Abstract (Originalsprache)
Somatostatin (SST) is a neuropeptide widely expressed in the central nervous system, known to exert inhibitory effects through the activation of G protein-coupled somatostatin receptors (SSTRs). Although its synaptic and network-level functions have been implicated in various neurological disorders, the direct peptidergic actions of SST-particularly on microglia-remain poorly understood. Given that SST levels are reduced in Alzheimer's disease (AD) and that microglia predominantly express SSTR2, we hypothesized that SST modulates microglial function in both physiological and AD-related contexts. In this study, we demonstrate that SST treatment enhances phagocytic capacity and suppresses pro-inflammatory cytokine release in cultured microglia. Furthermore, SST overexpression in an AD mouse model reduced microglial density and amyloid-β plaque burden and improved hippocampus-dependent cognitive performance, indicating a protective effect mediated through microglial modulation. Our findings reveal a previously unrecognized role of SST in regulating microglial behavior and highlight the therapeutic potential of targeting the SST-SSTR signaling axis in neuroinflammatory and neurodegenerative diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Brain Sciences, Daegu Gyeongbuk Institute of Science and Technology (DGIST), 333 Techno Jungangdae-Ro, Hyeonpoong-Eup, Dalseong-Gun, Daegu 42988, South Korea; Center for Synapse Diversity and Specificity,…
- Department of Brain Sciences, Daegu Gyeongbuk Institute of Science and Technology (DGIST), 333 Techno Jungangdae-Ro, Hyeonpoong-Eup, Dalseong-Gun, Daegu 42988, South Korea.
- Neural Circuits Group, Korea Brain Research Institute (KBRI), Daegu 41062, South Korea.
Förderung
- Ministry of Science and ICT, South Korea
- Daegu Gyeongbuk Institute of Science and Technology
- National Research Foundation of Korea
- Ministry of Science ICT and Future Planning
Zitieren
APA
Jung, H., Hyun, G., Kim, S., Jeon, Y., Han, K. A., Lee, K. J., Ko, J., & Um, J. W. (2026). Somatostatin-induced modulation of microglial activity contributes to mitigating Alzheimer’s disease pathology. Brain, Behavior, and Immunity, 136, 106563. https://doi.org/10.1016/j.bbi.2026.106563
Vancouver
Jung H, Hyun G, Kim S, Jeon Y, Han KA, Lee KJ, et al. Somatostatin-induced modulation of microglial activity contributes to mitigating Alzheimer’s disease pathology. Brain, Behavior, and Immunity. 2026;136:106563. doi:10.1016/j.bbi.2026.106563
BibTeX
@article{Jung2026,
author = {Jung, Hyeji and Hyun, Gaeun and Kim, Seunghye and Jeon, Younghyeon and Han, Kyung Ah and Lee, Kea Joo and Ko, Jaewon and Um, Ji Won},
title = {Somatostatin-induced modulation of microglial activity contributes to mitigating Alzheimer’s disease pathology},
journal = {Brain, Behavior, and Immunity},
year = {2026},
volume = {136},
pages = {106563},
doi = {10.1016/j.bbi.2026.106563}
}
EUVIMED